Skip to main content
H

Hunan Jingfeng Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000908 LEI · 83680029LIJEDRQHLO62 Shenzhen Stock Exchange Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country CN China
Listing Shenzhen Stock Exchange 000908

About Hunan Jingfeng Pharmaceutical Co.,Ltd.

https://www.jfyiyao.com

Hunan Jingfeng Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company focuses on therapeutic areas including cardiovascular and cerebrovascular diseases, orthopedics, and oncology. Its product portfolio features specialized treatments such as Erigeron Breviscapus injections for cardiovascular health and sodium hyaluronate injections for joint health and surgical applications. The firm operates multiple production bases and research centers, emphasizing the integration of chemical drugs, biological products, and traditional Chinese medicine derivatives. By leveraging advanced formulation technologies, the company aims to provide high-quality generic and innovative medications. Its operations encompass the entire value chain from active pharmaceutical ingredient (API) production to finished dosage forms, targeting both clinical and retail markets.

Recent filings

No filings indexed yet

We are still gathering filings for Hunan Jingfeng Pharmaceutical Co.,Ltd.. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.